Neurology
Neurodegenerative disorders, central and peripheral nervous system conditions, movement disorders, and neurovascular disease.
Core & active disease programs
Alzheimer's Disease
$207.8B+ attributable cost
118 assets · 3 indications
Migraine
$104.7B attributable cost
51 assets · 1 indication
Diabetic Peripheral Neuropathic Pain
$101.0B+ attributable cost
16 assets · 2 indications
Multiple Sclerosis
$65.6B+ attributable cost
$35.2B$+ drug spend
44 assets · 3 indications
Parkinson's Disease
$25.4B attributable cost
119 assets · 1 indication
Epilepsy
$15.6B+ attributable cost
73 assets · 4 indications
Provisional & emerging programs (32)Early clinical pipeline & single-asset indications
Myasthenia Gravis
Lennox-Gastaut Syndrome
Amyotrophic Lateral Sclerosis
Developmental and Epileptic Encephalopathies
Narcolepsy
Acute Ischemic Stroke
Dravet Syndrome
Huntington's Disease
Chronic Inflammatory Demyelinating Polyneuropathy
Fibromyalgia
Spinal Muscular Atrophy
Acute Pain
Idiopathic Hypersomnia
Chronic Pain
Dementia with Lewy Bodies
Essential Tremor
Sedation of Mechanically Ventilated ICU Patients
Spinocerebellar Ataxia
Subarachnoid Hemorrhage
Alexander Disease
Chronic Low Back Pain
Contrast-Enhanced MRI
Friedreich Ataxia
Guillain-Barré Syndrome
Neurogenic Orthostatic Hypotension
Neuromuscular Blockade During General Anesthesia
Neuropathic Pain
Non-24-Hour Sleep-Wake Disorder
Postoperative Nausea and Vomiting
Tardive Dyskinesia
Cerebral Cavernous Malformation
Frontotemporal Dementia